These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 31552489)

  • 1. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
    Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
    Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
    Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
    J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
    Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
    Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
    Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
    Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG
    J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
    Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T
    Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
    Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
    Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
    Lin JT; Tsai KW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
    Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
    Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
    Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
    Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y
    Biomarkers; 2024 Jul; 29(5):276-284. PubMed ID: 38767408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
    Andreu Z; Otta Oshiro R; Redruello A; López-Martín S; Gutiérrez-Vázquez C; Morato E; Marina AI; Olivier Gómez C; Yáñez-Mó M
    Eur J Pharm Sci; 2017 Feb; 98():70-79. PubMed ID: 27751843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.